News

The new trial is the second Phase II study evaluating bavituximab in advanced breast cancer patients, and Peregrine also is conducting a third Phase II combination therapy trial

Alnylam said that its scientists will work closely with the laboratory of Marino Zerial, whose team is internationally recognized as being at the forefront of the intracellular trafficking

The Lupus biomarker panel has been developed using Sense Proteomic’s proprietary protein array technology that permits rapid identification of autoantibody biomarkers for cancer and autoimmune diseases, the company

The trial has two components. The first is an open-label, dose-escalating, non-randomized study of Reolysin given intravenously with docetaxel every three weeks. Standard dosages of docetaxel were delivered

The company released top-line results from its 163 patient, double-blind, placebo-controlled trial of Trizytek, an enzyme replacement therapy for patients with pancreatic insufficiency. Trizytek is a stable and

Perrigo said that it won a patent challenge for Famotidine Complete, the national brand equivalent to Pepcid Complete marketed by Johnson & Johnson – Merck Consumer Pharmaceuticals. The

The company said that the Durata lead incorporates a soft silicone tip with a larger surface area and a slightly curved right ventricle shock coil intended to enhance

Ethicon Endo-Surgery said that the acquisition will provide the company with a new energy platform, which complements its Harmonic line of ultrasonic medical devices that have been used

NeoGenomics will support Gene Express in its FDA validation of its lung cancer risk prediction and BCR/ABL tests. The agreements will also allow NeoGenomics to commercialize Gene Express